• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Taking Another Look at Economic Moats

    Morningstar recently upgraded several companies' moat ratings, and global equity research director Heather Brilliant explains why.

  2. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  3. Three Frontrunners for CEO of the Year 2012

    CEOs from three moat-worthy firms are in the running for this year's award.

  4. Weighty Decisions

    Morningstar markets editor Jeremy Glaser charts the week's decision points for Best Buy, Walgreen, the Supreme Court, and more.

  1. Dow's Record No Reason to Abandon Stocks

    Stocks may be fully valued, but there are still some equities at bargain prices.

  2. Readers Share Top Picks for an Uninspiring Market

    Some users find value in dividend-paying blue chips, while others are compiling watchlists and waiting for a pullback.

  3. Express Scripts ESRX Q4 2012 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to the Fourth Quarter 2012 Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session, instructions will be given at that time. As a reminder, this conference is being ...

  4. Express Scripts ESRX Q3 2012 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by and welcome to the Express Scripts Third Quarter 2012 Earnings Conference Call. For the conference, all participants are in a listen-only mode. There will be an opportunity for your questions instructions will be given at that time. As a reminder, ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.